// App-Quantinova.ai

PB0647 : Who May Benefit from Direct Oral Anticoagulant Level Monitoring? A Systematic Literature Review

Researchers

Presenter

  • R. Vicente-Steijn

Principal Investigators

  • Y.M.C. Henskens

  • M. Coppens

  • S. Middeldorp

  • A.K. Stroobants

Medical Centers

  • OLVG Lab BV, Laboratory of Hematology and Clinical Chemistry, Amsterdam, The Netherlands

  • Maastricht University Medical Center, Central Diagnostic Laboratory, Unit for Hemostasis and Transfusion, Maastricht, the Netherlands

  • Amsterdam UMC, University of Amsterdam, Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands

  • Amsterdam UMC, University of Amsterdam, Department of Clinical Chemistry, Amsterdam, the Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

  • Arrhythmia

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • betrixaban

  • Pradax

  • apixaban

  • Edoxaban

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved